Hydralazine Hydrochloride 50111-0327-01
- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 30, 1990
- Listing Expires
- December 31, 2026
- Application
- ANDA088467
Need to source Hydralazine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydralazine Hydrochloride | 25 mg/1 |
Drug Class
Arteriolar Vasodilation [PE]Arteriolar Vasodilator [EPC]
Selected Package
50111-0327-01Selected100 TABLET in 1 BOTTLE (50111-327-01)
Other packages for this product(1)
1000 TABLET in 1 BOTTLE (50111-327-03)